Fifth American with Ebola Lands in Nebraska for Treatment
The first man diagnosed with Ebola in the US is begin treated with an experimental medication, officials say, after announcing on Sunday that he is “fighting for his life”.
The Texas Health Presbyterian hospital in Dallas said on Monday that Thomas Eric Duncan began receiving the experimental antiviral drug brincidofovir, made by North Carolina-based biopharmaceutical company Chimerix, on Saturday.
Duncan’s condition worsened over the weekend, and on Monday the hospital said he remains in critical but stable condition.
“Based on in-vitro data from work conducted by the CDC and the National Institutes of Health, we are hopeful that brincidofovir may offer a potential treatment for Ebola during this outbreak,” Dr Michelle Berrey, the president and CEO of Chimerix, said in a statement.
She said requests for the drug were made by treating physicians. The company received federal approval to use the drug, which is in late-stage testing.